Caladrius Biosciences أخبار Eulerpool

Caladrius Biosciences إيولربول AFX

أخبار سهم Caladrius Biosciences

يتابع Caladrius Biosciences العديد من الصحفيين والمستثمرين حول العالم. نقدم هنا أحدث أخبار Caladrius Biosciences.

• ١٤ سبتمبر ·

  Thefly.com
  Caladrius announces approval of merger, name change to Lisata Therapeutics
• ١٢ سبتمبر ·

  Yahoo
  Life Sciences Virtual Investor Conference Agenda Announced for September 15th
• ٨ سبتمبر ·

  Yahoo
  Caladrius Biosciences Announces Participation in Upcoming Investor Conferences in September 2022
• ٢ سبتمبر ·

  InvestorPlace
  Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
• ١٠ أغسطس ·

  Yahoo
  Caladrius Biosciences’ Prospective Merger Partner, Cend Therapeutics, Announces Collaboration Agreement with Roche to Evaluate CEND-1 in Combination with Immunotherapy to Treat Pancreatic Cancer
• ١٠ أغسطس ·

  TipRanks
  Analysts Conflicted on These Healthcare Names: Haemonetics (HAE), Caladrius Biosciences (CLBS) and Adicet Bio (ACET)
• ١٠ أغسطس ·

  Thefly.com
  Caladrius announces Cend's agreement with F. Hoffmann-La Roche
• ٧ أغسطس ·

  TipRanks
  Dawson James Sticks to Its Hold Rating for Caladrius Biosciences (CLBS)
• ٥ أغسطس ·

  TipRanks
  H.C. Wainwright Thinks Caladrius Biosciences’ Stock is Going to Recover
• ٥ أغسطس ·

  SeekingAlpha
  Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q2 2022 Results - Earnings Call Transcript